1 / 60

COMMON ENDEMIC INFECTIOUS DISEASES IN SAUDI ARABIA

COMMON ENDEMIC INFECTIOUS DISEASES IN SAUDI ARABIA. MAP. BRUCELLOSIS. MICROBIOLOGY. 6 SPECIES, 4 CAN BE TRANSMITTED TO MAN. GRAM NEGATIVE, NON-MOTILE, NON-SPORE FORMING. THE ORGANISM IS FACULATIVE. CULTURE CAN TAKE LONG TIME. SURVIVAL CAN BE VERY LONG.

sopoline-tran
Télécharger la présentation

COMMON ENDEMIC INFECTIOUS DISEASES IN SAUDI ARABIA

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. COMMON ENDEMIC INFECTIOUS DISEASES IN SAUDI ARABIA

  2. MAP

  3. BRUCELLOSIS

  4. MICROBIOLOGY • 6 SPECIES, 4 CAN BE TRANSMITTED TO MAN. • GRAM NEGATIVE, NON-MOTILE, NON-SPORE FORMING. • THE ORGANISM IS FACULATIVE. • CULTURE CAN TAKE LONG TIME. • SURVIVAL CAN BE VERY LONG. • OPTIMUM TEMPERATRE IS 37 °C (20-40 °C)

  5. BRUCELLOSIS & OTHER RISK FACTORS

  6. REGIONAL DISTRIBUTION OF SEROPOSITIVITY ACCORDING TO THE MICROPLATE AGGLUTINATION TEST

  7. Prevalence of Brucellosis in Al-Qaseem Area Al-Balla S.R. Unpublished data

  8. PMN T Suppresser Ant. Pr. Cell T. helper B cell Macrophage Elimination OR

  9. AFTER ENTERING THE BODY Leukocyte OR Regional Lymph node OR Blood Stream Liver Spleen Bone Marrow Lymph Node OR Microgranuloma Micro abscess formation OR OR Blood Stream BLOOD STREAM BLOOD STREAM BLOOD STREAM

  10. FREQUENCY OF COMMON SYMPTOMS IN STUDIES FROM SAUDI ARABIA

  11. CLINICAL FINDINGS

  12. POSITIVE BLOOD CULTURES FOR BRUCELLA

  13. SEROLOGICALTESTS • STANDARD TUBE AGGLUTINATION TEST • MICROPLATE AGGLUTINATION TEST • 2-MERCAPTOETHANOL AGGLUTINATION TEST • COOMBS TEST • COMPLEMENT FIXATION TEST • ROSE BENGAL TEST • ENZYME-LINKED IMMUNOSORBENT ASSAY • GEL PRECIPITAITON TEST

  14. ACTIVE DISEASE • Clinical evidence (symptoms & signs) of brucellosis plus: • Positivity at > 1:160 by STAT • Positivity at > 1:140 by 2-ME test • Positivity by ELISA (high IgG & low IgM)

  15. TREATMENT FOR HUMAN BRUCELLOSIS

  16. TREATMENTFOR HUMAN BRUCELLOSIS

  17. COMPARATIVESTUDY OF 3 DRUGS REGIMENS

  18. VACCINES • B. abortus strain 19 • B. melitensis strain Rev I • B. suis strain 2s • B. abortus strain 45/20 • B. melitensis strain H38

  19. PREVENTION • “ELIMINATION OF THE DISEASE IN ANIMALS” • PERSONAL HYGIENE (WASHING EXPOSED CLOTHES) • ENVIRONMENTAL SANITATION (DISPOSAL OF CONTAMINATED SUBSTANCES) • PASTURIZATION OF DIARY PRODUCTS • HEALTH EDUCATION • IMMUNIZATION

  20. SCHISTOSOMIASIS

  21. PREVALENCE OF SCHISTOSOMIASIS AS REPORTED BY THE STATION __________________________________________ Prevalence (%) No. of Overall Persons S. Haema- S.Man- Preva Station Examined tobium soni lence+ ____________________________________________ Al Baha 20.142 -- 13.0 13.0 Jizan 30.883 7.0 1.2 8.2 Taif 39.559 0.2 7.7 7.9 Abha 23.013 1.7 4.9 6.6 Madinah 17.591 1.9 3.6 5.5

  22. Prevalence (%) No. of Overall Persons S. Haema- S.Man- Preva Station Examined tobium soni lence+ ____________________________________________ Bisha 16.766 0.4 8.5 8.9 Najran 8.820 1.6 9.9 11.5 Mahael 5.783 7.6 --- 7.6 Hayil 4.335 --- 14.2 12.2 Riyadh 15.129 --- 5.6 5.6 Makkah 25.894 2.5 3.0 5.5 Al-Jouf 12.577 1.3 1.6 2.9

  23. Portal Vein

  24. S P Inf. Mesentery Rectal

  25. KATAYAMA FEVER(KATAYAMA River, Japan) • SEVERAL DAYS – 2-3 WEEKS • FEVER, CHILLS, HEADACHE, MALAISE, EDEMA, CONFUSION • HEPATOSPLENOMEGALLY • LYMPHADENOPATHY • EOSINOPHILIA • CEREBRAL EDEMA (CT)

  26. S. MANSONI (SYMPTOMS

  27. What is the most serious common complication of Schistosomiasis infection?

  28. Oes. varices

  29. Communication with Systemic Circulation

  30. Pulmonary Artery

  31. S. HAEMATOBIUM

  32. U SCHISTOSOMIASIS Kidney U. Bladder

  33. SIDE EFFECTS OF ANTISCHISTOSOMAL DRUGS (%)

  34. SALMONELLA TYPHOID FEVER

  35. CLASSIFICATION OF SALMONELLA • According to their ecologic niches • Serotyping [kanfmann white] • O antigen A-I • H antigen (subtypes) * Over 2000 serotypes

  36. Spectrum of clinical manifestations of salmonella • Gastroenteritis • Enteric fever • Bacteremia • With metastatic disease • Without metastatic disease • Asymptomatic carrier state

  37. S. PATHOGENESIS • ID 10ˆ6 – 10ˆ9 • Penetration of the distal ileum mucosa • Multiplication in the payer patches • Diarrhea is caused by: • Prostlaglandin Induced ˆ (c-AMP) • Local Inflamatory rasponce • S. enterotoxin

  38. TYPHOID FEVER(Enteric Fever) • Definition: A disease characterized by prolonged fever, abdominal pain, diarrhea, delirium, rash (rose spots) & splenomegally. • Etiology: Salmonella Typhi & paratyphi A & B-A motile gram-negative bacilli, which possess: • H-Antigen (associated with flagella) • O-Antigen (a LPS associated with cell wall) • VI-Antigen (a PS associated with cell capsule)

  39. EPIDEMIOLOGY OF TYPHOID FEVER • It affects all age groups. • No sex difference. • Common in developing countries. • Infecting dose 7x10(6) in Africa, Asia & Latin America. • Transmission is through Oral-fecal route. • Affected individuals may become asymptomatic carriers particularly females & older males (Underlying cholecystitis). • S-Typhi is resistant to drying & cooling.

  40. SYMPTOMS & SIGNS

  41. SIGNS & SYMPTOMS(cont,) ______________________________________ Symptoms Signs Pathology _____________________________________________________________ 3rd wk Intestinal Melena Ulcerations, perforation bleeding, per- rigid abdomen with peritonitis. foration & shock ileus, coma ____________________________________________________________ 4th week Resolution Recurrence Cholecystitis, chronic & later relapse of acute fecal carriage of bacteria weight loss disease, cachexia.

  42. ANTIBIOTIC USED FOR SALMONELLA TYPHI • Chloramphenicol • Ampicillin, Amoxil • Co-trimoxazole • 3rd generation cephalosporins • Quinolones

  43. PROGNOSIS • Case fatality dropped 12% to 4% • It is still +\- 10% in developing countries • Perforation +\- 5% • Chronic fecal carriers 1-3%

  44. VACCINATION FOR S.TYPHI • Inativated S.typhi: • 2 SC injections: • 55-88% protection for 3-5yr. • Attenuated S.typhi: • Liquid 3 doses • Enteric coated capsules • Protection 60-70%

  45. LEISHMANIASIS

  46. LEISHMANIASIS It is the result of the infection with one of or other species of protozoa (leishmania). Conveyed by: Sandflies (Phlebotomus). Visceral Leishmaniasis: L. donovani Mucocutaneous : L. Braziliensis

  47. Cutaneous : L.tropica major L. tropica minor New World : L. Braziliensis L. Mexicana Old world

  48. PATHOLOGY » L. donovani parasitizes the reticu. endoth. cells » Great proliferation of macrophage » Cells result: Liver – spleen enlarg. » The red bone marrow extend. »

  49. CLINICAL PICTURE • Incubation: 2 weeks – 18 months early stages is not easy for diagnose. There is no constant physical signs. BP , Pulse , - Fever ☺ Changes in the blood picture particularly Leucopenia. ☺ Outstanding physical sign is the enlargement of the spleen 3 cm. a month.

  50. ● Liver : enlarged spleen + liver are neither tender nor painful. ● Sometimes: Jaundice = prognost. Significance ● Enlarged : Lymph node, could be but its not a feature of the disease. ● Wasting : Emaciated pat with a protuberant

More Related